Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
about
Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.The NAD World 2.0: the importance of the inter-tissue communication mediated by NAMPT/NAD+/SIRT1 in mammalian aging and longevity control.Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.The brain, sirtuins, and ageing.Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions.Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.NAD + biosynthesis, aging, and disease.The Influence of Nicotinamide on Health and Disease in the Central Nervous System.The Emergence of the Nicotinamide Riboside Kinases in the regulation of NAD+ Metabolism.Quinacrine pretreatment reduces microwave-induced neuronal damage by stabilizing the cell membrane.Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock
P2860
Q33677954-D6A098F3-B50B-413A-A500-E6343AAFA9F2Q33917839-4DB8E03C-773C-4818-AC49-2AFBD0BFB52BQ38678550-6B6D491D-D3E4-4DC1-B07C-38B8F678D1FDQ39313687-421380DE-9F15-4046-9145-E4D7DCB86A95Q39447083-FBAC2D6B-E553-4AC3-89B7-E37D84BFF966Q41068775-267D74C6-AD7E-4E1C-8AA3-0C7953F96943Q46360856-A22197EF-C472-4500-8A52-0B77EE000C67Q46514631-23D75790-A19B-41ED-A22A-8D58272F36F7Q47130925-6499C21C-3C2B-4975-85EE-69C2A38D40EAQ47947055-E6971F76-6DC3-41B3-BBF9-1E8F64BF7C0AQ49712935-84C2AA55-87B0-4668-804A-36A22CE68A3DQ50063845-2A97B3C0-2C74-4F7F-AA36-03FDCA034592Q54940937-917E8FBF-CD7B-4CFE-B4F1-3213FBCB5964Q54968514-40121484-A3D5-4C1B-9E15-DC9B3F7D3CF2Q54977650-87772982-0595-468F-8911-C987AA70AB0FQ55387592-598E7771-7C7D-416B-9290-0E901180FCB3Q58760694-99F2DFC0-BA48-4BC3-B6DC-BFE9329C5F43
P2860
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@ast
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@en
type
label
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@ast
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@en
prefLabel
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@ast
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@en
P2093
P2860
P1433
P1476
Effect of nicotinamide mononuc ...... disease-relevant murine model.
@en
P2093
Aaron N Long
Anna E Schlappal
Katrina Owens
Paul S Fishman
Rosemary A Schuh
Tibor Kristian
P2860
P2888
P356
10.1186/S12883-015-0272-X
P577
2015-03-01T00:00:00Z
P5875
P6179
1042370877